Zerify (ZRFY) S-1 5 Aug 22 IPO registration Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2022
Document Information Line Items
Entity Registrant Name	Zerify, Inc.
Entity Central Index Key	0001285543
Document Type	S-1
Amendment Flag	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Filer Category	Non-accelerated Filer
Entity Incorporation State Country Code	WY
Entity Tax Identification Number	22-3827597
Entity Address Address Line 1	1090 King Georges Post Road
Entity Address Address Line 2	Suite 603
Entity Address City Or Town	Edison
Entity Address State Or Province	NJ
Entity Address Postal Zip Code	08837
City Area Code	732
Local Phone Number	661-9641
Business Contact [Member]
Document Information Line Items
Entity Address Address Line 1	1090 King Georges Post Road
Entity Address Address Line 2	Suite 603
Entity Address City Or Town	Edison
Entity Address State Or Province	NJ
Entity Address Postal Zip Code	08837
City Area Code	732
Local Phone Number	661-9641
Contact Personnel Name	Mark Kay

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash (includes VIE balances of $1,000 and $1,000, respectively)	$ 974,000	$ 2,084,000	$ 162,000
Accounts receivable, net	14,000	24,000	20,000
Prepaid expenses	2,000	13,000	21,000
Total current assets	990,000	2,121,000	203,000
Property and equipment, net	24,000	0	2,000
Operating lease right-of-use asset	94,000	107,000	157,000
Other assets	12,000	12,000	14,000
Total Assets	1,120,000	2,240,000	376,000
Current Liabilities:
Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively)	1,042,000	996,000	1,010,000
Convertible notes payable (including $895,000 and $895,000 in default, respectively)	1,378,000	1,398,000	1,469,000
Convertible notes payable - related parties	268,000	268,000	298,000
Notes payable (including $1,965,000 and $1,972,000 in default, respectively) (includes VIE balances of $310,000 and $310,000, respectively)	1,965,000	1,972,000	2,250,000
Notes payable - related parties	693,000	693,000	952,000
Accrued interest (including $1,527,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $126,000 and $120,000, respectively)	5,577,000	5,477,000	5,187,000
Contingent payment obligation	1,500,000	1,500,000	1,500,000
VIE Financing obligation	1,263,000	1,263,000	1,263,000
Operating lease liability, current portion	55,000	39,000	38,000
Derivative liabilities		0	163,000
Total current liabilities	13,741,000	13,606,000	14,130,000
Notes payable, long-term portion	150,000	150,000	463,000
Operating lease liability, long term portion	43,000	73,000	125,000
Total Liabilities	13,934,000	13,829,000	14,718,000
Stockholders' Deficit
Preferred stock series not designated par value $0.10: 10,000,000 shares authorized; none issued or outstanding	0	0	0
Common stock par value $0.0001: 4,000,000,000 shares authorized; 955,515,078 and 955,380,225 shares issued and outstanding, respectively	96,000	96,000	72,000
Additional paid-in capital	61,430,000	59,788,000	39,814,000
Accumulated deficit	(74,455,000)	(71,595,000)	(54,396,000)
Total Zenify, Inc. stockholders' deficit	(11,938,000)	(10,720,000)	(13,519,000)
Noncontrolling interest in consolidated subsidiary	(876,000)	(869,000)	(823,000)
Total Stockholders' Deficit	(12,814,000)	(11,589,000)	(14,342,000)
Total Liabilities and Stockholders' Deficit	1,120,000	2,240,000	376,000
Series A Preferred Stock [Member]
Stockholders' Deficit
Preferred stock series not designated par value $0.10: 10,000,000 shares authorized; none issued or outstanding	987,000	987,000	987,000
Series B Preferred Stock [Member]
Stockholders' Deficit
Preferred stock series not designated par value $0.10: 10,000,000 shares authorized; none issued or outstanding	$ 4,000	$ 4,000	$ 4,000

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current Assets
Cash VIE	$ 1,000	$ 1,000	$ 2,000
Current Liabilities
Accounts payables	4,000	2,000	3,000
Convertible notes payable, net of discount		0	14,000
Convertible notes payable, default	895,000	895,000	1,458,000
Notes payable, default	1,965,000	1,972,000	2,146,000
Notes payable VIE	310,000	310,000	475,000
Notes payable, net of discount		0	52,000
Financing obligation VIE		1,263,000	1,263,000
Accrued interest due to related parties	1,527,000	1,497,000	1,448,000
Accrued Interest VIE	$ 126,000	$ 120,000	$ 109,000
Stockholders' Deficit
Preferred Stock, share par value	$ 0.01	$ 0.10	$ 0.10
Preferred stock, shares authorized	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	4,000,000,000	4,000,000,000	4,000,000,000
Common stock, shares issued	955,515,078	955,380,225	718,263,338
Common stock, shares outstanding	955,515,078	955,380,225	718,263,338
Preferred Stock Series B [Member]
Stockholders' Deficit
Preferred Stock, share par value	$ 0.10	$ 0.10	$ 0.10
Preferred stock, shares authorized	10,000,000	100,000,000	100,000,000
Preferred stock, shares issued	36,667	36,667	36,667
Preferred stock, shares outstanding	36,667	36,667	36,667
Preferred Stock Series A [Member]
Stockholders' Deficit
Preferred stock, shares authorized	100	100	100
Preferred stock, shares issued	3	3	3
Preferred stock, shares outstanding	3	3	3

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 32,000	$ 46,000	$ 193,000	$ 207,000
Operating expenses:
Cost of revenue	10,000	3,000	27,000	13,000
Selling, general and administrative expenses	2,636,000	5,628,000	9,448,000	2,350,000
Research and development	154,000	145,000	566,000	520,000
Total operating expenses	2,800,000	5,776,000	10,041,000	2,883,000
Loss from operations	(2,768,000)	(5,730,000)	(9,848,000)	(2,676,000)
Other income (expense):
Interest expense (including $30,000 and $31,000 to related parties, respectively)	(99,000)	(128,000)	(447,000)	(654,000)
Debt discount amortization	0	23,000	(52,000)	(605,000)
Financing costs	0	(3,239,000)	(6,569,000)	0
Private placement costs			0	(175,000)
Change in fair value of derivative liabilities	0	(219,000)	(219,000)	(1,190,000)
Loss on extinguishment of debt, net	0	(607,000)	(109,000)	(4,841,000)
Other income (expense)			(1,000)	53,000
Other income (expense), net	(99,000)	(4,216,000)	(7,397,000)	(7,412,000)
Net loss	(2,867,000)	(9,946,000)	(17,245,000)	(10,088,000)
Net loss attributable to noncontrolling interest	7,000	7,000	46,000	45,000
Net loss attributable to Zerify, Inc.	$ (2,860,000)	$ (9,939,000)	$ (17,199,000)	$ (10,043,000)
Net loss per common share
-Basic and diluted	$ 0	$ (0.01)	$ (0.02)	$ (0.14)
Weighted average common shares outstanding
-Basic and diluted	955,465,906	777,075,644	868,770,818	73,260,600

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Series A Preferred Stock,no par value [Member]	Series B Preferred Stock par value $0.10 [Member]	Common Stock,par value $0.0001 [Member]	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest
Balance, shares at Dec. 31, 2019		3	36,667	5,905,388
Balance, amount at Dec. 31, 2019	$ (15,464,000)	$ 987,000	$ 4,000	$ 1,000	$ 28,675,000	$ (44,353,000)	$ (778,000)
Common stock issued for cash, shares				436,337,203
Common stock issued for cash, amount	976,000	0	0	$ 44,000	932,000	0	0
Fair value of common stock issued for services, shares				6,378,671
Fair value of common stock issued for services, amount	39,000	0	0	$ 1,000	38,000	0	0
Fair value of vested options	506,000	0	0	0	506,000	0	0
Warrants issued with notes payable accounted for as debt discount	118,000	0	0	$ 0	118,000	0	0
Common stock issued upon conversion of notes payable and accrued interest, shares				233,674,842
Common stock issued upon conversion of notes payable and accrued interest, amount	9,112,000	0	0	$ 23,000	9,089,000	0	0
Common stock issued upon conversion of debt settlement, shares				35,967,234
Common stock issued upon conversion of debt settlement, amount	459,000	0	0	$ 3,000	456,000	0	0
Net loss	(10,088,000)	$ 0	$ 0	$ 0	0	(10,043,000)	(45,000)
Balance, shares at Dec. 31, 2020		3	36,667	718,263,338
Balance, amount at Dec. 31, 2020	(14,342,000)	$ 987,000	$ 4,000	$ 72,000	39,814,000	(54,396,000)	(823,000)
Common stock issued for cash, shares				38,116,450
Common stock issued for cash, amount	1,449,000	0	0	$ 4,000	1,445,000	0	0
Fair value of common stock issued for services, shares				128,527
Fair value of common stock issued for services, amount	16,000	$ 0	$ 0		16,000
Fair value of vested options	5,230,000				5,230,000
Common stock issued upon conversion of notes payable and accrued interest, shares				16,168,589
Common stock issued upon conversion of notes payable and accrued interest, amount	1,035,000			$ 2,000	1,033,000
Common stock issued upon conversion of debt settlement, shares				460,829
Common stock issued upon conversion of debt settlement, amount	88,000				88,000
Net loss	(9,946,000)					(9,939,000)	(7,000)
Fair value of common stock issued as a financing cost, shares				16,931,437
Fair value of common stock issued as a financing cost, amount	3,239,000			$ 1,000	3,238,000
Common stock issued upon cashless exercise of options, shares				17,208,335
Common stock issued upon cashless exercise of options, amount				$ 2,000	(2,000)
Balance, shares at Mar. 31, 2021		3	36,667	807,277,505
Balance, amount at Mar. 31, 2021	(13,231,000)	$ 987,000	$ 4,000	$ 81,000	50,862,000	(64,335,000)	(830,000)
Balance, shares at Dec. 31, 2020		3	36,667	718,263,338
Balance, amount at Dec. 31, 2020	(14,342,000)	$ 987,000	$ 4,000	$ 72,000	39,814,000	(54,396,000)	(823,000)
Common stock issued for cash, shares				119,666,450
Common stock issued for cash, amount	5,368,000	0	0	$ 12,000	5,356,000	0	0
Fair value of common stock issued for services, shares				3,365,138
Fair value of common stock issued for services, amount	181,000	0	0	$ 1,000	180,000	0	0
Fair value of vested options	6,757,000	0	0	$ 0	6,757,000	0	0
Common stock issued upon conversion of notes payable and accrued interest, shares				16,168,589
Common stock issued upon conversion of notes payable and accrued interest, amount	1,035,000	0	0	$ 2,000	1,033,000	0	0
Common stock issued upon conversion of debt settlement, shares				460,829
Common stock issued upon conversion of debt settlement, amount	88,000	0	0	$ 0	88,000	0	0
Net loss	(17,245,000)	0	0	$ 0	0	(17,199,000)	(46,000)
Fair value of common stock issued as a financing cost, shares				45,150,500
Fair value of common stock issued as a financing cost, amount	6,569,000	0	0	$ 5,000	6,564,000	0	0
Common stock issued upon cashless exercise of options, shares				39,955,655
Common stock issued upon cashless exercise of options, amount	0	0	0	$ 3,000	(3,000)	0	0
Fair value of warrants issued for services	0	0	0	$ 0	0	0	0
Common stock issued upon cashless exercise of warrants, shares				12,349,726
Common stock issued upon cashless exercise of warrants, amount	0	$ 0	$ 0	$ 1,000	(1,000)	0	0
Balance, shares at Dec. 31, 2021		3	36,667	955,380,225
Balance, amount at Dec. 31, 2021	(11,589,000)	$ 987,000	$ 4,000	$ 96,000	59,788,000	(71,595,000)	(869,000)
Fair value of common stock issued for services, shares				134,853
Fair value of common stock issued for services, amount	6,000	0	0	$ 0	6,000	0	0
Fair value of vested options	1,636,000	0	0	0	1,636,000	0	0
Net loss	(2,867,000)	$ 0	$ 0	$ 0	0	(2,860,000)	(7,000)
Balance, shares at Mar. 31, 2022		3	36,667	955,515,078
Balance, amount at Mar. 31, 2022	$ (12,814,000)	$ 987,000	$ 4,000	$ 96,000	$ 61,430,000	$ (74,455,000)	$ (876,000)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (2,867,000)	$ (9,946,000)	$ (17,245,000)	$ (10,088,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	0	1,000	4,000	7,000
Amortization of discount	0	23,000	52,000	605,000
Amortization of right-of-use asset	13,000	12,000
Fair value of common stock issued for services	6,000	16,000	181,000	39,000
Fair value of vested options	1,636,000	5,230,000	6,757,000	506,000
Fair value of common stock issued for financing services	0	3,239,000	6,569,000	0
Change in fair value of derivative liabilities	0	219,000	219,000	1,190,000
Private placement costs			0	173,000
Loss on extinguishment of debt, net	0	607,000	112,000	4,841,000
Interest expense from debt settlement obligation			0	0
Changes in operating assets and liabilities:
Accounts receivable	10,000	3,000	(4,000)	0
Prepaid expenses	11,000	(2,000)	8,000	(17,000)
Right-of-use asset			51,000	49,000
Accounts payable and accrued expenses	46,000	(8,000)	(14,000)	(77,000)
Accrued interest	99,000	34,000	298,000	562,000
Operating lease liability	(14,000)	(13,000)	(51,000)	(46,000)
Net cash used in operating activities	(1,060,000)	(585,000)	(3,063,000)	(2,256,000)
Cash flows from investing activities:
Purchases of property and equipment	(24,000)	0	0	(1,000)
Net cash used in investing activities	(24,000)	0	0	(1,000)
Cash flows from financing activities:
Proceeds from sale of common stock	0	1,449,000	5,368,000	976,000
Proceeds from convertible notes payable			0	803,000
Proceeds from notes payable	0	177,000	177,000	673,000
Proceeds from notes payable-related parties			0	263,000
Repayment of convertible note payable	(20,000)	0	(40,000)	(43,000)
Repayment of notes payable	(6,000)	(97,000)	(231,000)	(274,000)
Repayment of convertible notes payable-related parties	0	(30,000)	(30,000)	0
Repayment of notes payable-related parties	0	(260,000)	(259,000)	(54,000)
Net cash provided by (used in) financing activities	(26,000)	1,239,000	4,985,000	2,344,000
Net increase (decrease) in cash	(1,110,000)	654,000	1,922,000	87,000
Cash at beginning of the year	2,084,000	162,000	162,000	75,000
Cash at end of the period	974,000	816,000	2,084,000	162,000
Supplemental disclosure of cash flow information:
Interest paid	0	76,000	120,000	85,000
Income tax paid	0	0	0	0
Supplemental disclosure of non-cash investing and financing transactions
Common stock issued for conversion of notes and accrued interest	0	1,035,000	1,035,000	9,112,000
Common stock issued upon conversion of debt settlement	$ 0	$ 88,000	88,000	459,000
Fair value of derivative upon issuance of convertible debt recorded as debt discount			0	744,000
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			0	198,000
Convertible note and accrued interest exchanged for common stock			0	1,180,000
Warrants issued with convertible notes			$ 0	$ 118,000

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies
Organization and Summary of Significant Accounting Policies	Note 1 - Organization and Summary of Significant Accounting Policies Zerify, Inc. (the “Company”) is a software development and services company that offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey. Basis of presentation and principles of consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been included. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2022. These financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2021 and notes thereto contained in the Annual Report on Form 10-K of the Company as filed with the SEC on April 14, 2022. The condensed consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. At March 31, 2022, noncontrolling interests represents 51% of BST that the Company does not directly own. The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years. The management fee is eliminated in consolidation. At March 31, 2022 and December 31, 2021, the amount of VIE cash on the accompanying condensed consolidated balance sheets can be used only to settle obligations of BST, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the general credit of the Company. Going Concern We have yet to establish any history of profitable operations. During the three months ended March 31, 2022, the Company incurred a net loss of $2,867,000 and used cash in operating activities of $1,060,000, and at March 31, 2022, the Company had a stockholders’ deficit of $12,814,000. In addition, we are in default on notes payable and convertible notes payable in the aggregate amount of $2,861,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report published on our December 31, 2021 year-end financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern. Management estimates that the current funds on hand will be sufficient to continue operations through the next six months. Our ability to continue as a going concern is dependent upon our ability to continue to implement our business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of its strategy to increase revenues, there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon our ability to increase our customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing. COVID-19 In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally. It has also disrupted the normal operations of many businesses. This outbreak could decrease spending, adversely affect demand for the Company’s products, and harm the Company’s business and results of operations. During the three months ended March 31, 2022 and the year ended December 31, 2021, the Company believes the COVID-19 pandemic did impact its operating results. For the three months ended March 31, 2022 and the year ended December 31, 2021, sales to customers decreased by 30% and 7%, respectively, as compared to the prior year. However, the Company has not observed any impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. At this time, it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. Revenue Recognition The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust® and SafeVchat™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Three months ended March 31, 2022 March 31, 2021 Software $ 32,000 $ 45,000 Service - 1,000 Total revenue $ 32,000 $ 46,000 Fair Value of Financial Instruments The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. All outstanding derivative financial instruments were extinguished during fiscal year 2021. Stock-Based Compensation The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton option pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. Loss per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Three months ended March 31, 2022 March 31, 2021 Options to purchase common stock 83,133,001 40,633,001 Warrants to purchase common stock 68,981,234 27,355,475 Convertible notes 21 21 Convertible Series B Preferred stock 1,284,394 492,455 Total 153,398,650 68,480,952 Concentrations For the three months ended March 31, 2022, sales to four customers comprised 38%, 26%, 11% and 10% of revenues. For the three months ended March 31, 2021, sales to two customers comprised 72% and 15% of revenues. At March 31, 2022, two customers comprised 59% and 18% of accounts receivable. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At March 31, 2022, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. Segments The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.	Note 1 - Organization and Summary of Significant Accounting Policies Zerify, Inc. (the “Company”) is a software development and services company that offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey. Going Concern At December 31, 2021, the Company had cash on hand in the amount of $2,084,000. Management estimates that the current funds on hand will be sufficient to continue operations through the next twelve months. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While the Company believes in the viability of its strategy to increase revenues, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing. Basis of presentation and principles of consolidation At December 31, 2021, noncontrolling interests represents 51% of BST that the Company does not directly own. The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years. The management fee is eliminated in consolidation. At December 31, 2021 and 2020, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the general credit of the Company. Reverse Stock Split COVID-19 In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally. It has also disrupted the normal operations of many businesses. This outbreak could decrease spending, adversely affect demand for the Company’s products, and harm the Company’s business and results of operations. During the years ended December 31, 2021 and 2020, the Company believes the COVID-19 pandemic did impact its operating results. For the years ended December 31, 2021 and 2020, sales to customers decreased by 7% and 73%, respectively, as compared to the prior year. However, the Company has not observed any impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. At this time, it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. Revenue Recognition The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust® and SafeVchat™ products. The Company usually recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Year ended December 31, 2021 December 31, 2020 Software $ 193,000 $ 200,000 Service - 7,000 Total revenue $ 193,000 $ 207,000 Accounts Receivable Accounts receivable consist of trade amounts due from customers, and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2021 and 2020, the allowance for doubtful accounts was $20,000 and $20,000, respectively. Property and Equipment Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows: Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7 Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2021 and 2020, the Company did not recognize any impairment for its property and equipment. Impairment of Long-lived Assets The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, including intangible assets other than goodwill, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2021 and 2020, the Company had no impairment of long-lived assets. Income Taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Leases We lease our corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 11). Fair Value of Financial Instruments The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of December 31, 2020, the Company’s balance sheet includes Level 2 liabilities comprised of the fair value of embedded derivative liabilities of $163,000 (see Note 10). Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Stock-Based Compensation The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. Loss per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Year ended December 31, 2021 December 31, 2020 Options to purchase common stock 83,133,001 58,133,001 Warrants to purchase common stock 68,981,234 27,405,476 Convertible notes 21 1,156,304 Convertible Series B Preferred stock 1,255,638 791,170 Total 153,369,894 87,485,950 Advertising, Sales and Marketing Costs Research and Development Costs Concentrations For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. For the year ended December 31, 2020, sales to two customers comprised 72% and 15% of revenues, respectively. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively. At December 31, 2020, three customers comprised 50%, 24% and 10% of accounts receivable, respectively. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At December 31, 2021, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. Segments The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property and Equipment
Property and Equipment	Note 2 - Property and Equipment Property and equipment, stated at cost, less accumulated depreciation consisted of the following: December 31, 2021 December 31, 2020 Computer equipment $ 82,000 $ 82,000 Computer software 44,000 44,000 Furniture and fixtures 10,000 10,000 Office equipment 17,000 17,000 153,000 153,000 Less accumulated depreciation (153,000 ) (151,000 ) $ - $ 2,000 Depreciation expense for the years ended December 31, 2021 and 2020 was $2,000 and $4,000, respectively.

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Convertible Notes Payable
Convertible Notes Payable	Note 2 - Convertible Notes Payable Convertible notes payable consisted of the following: March 31, 2022 December 31, 2021 Secured (a) Convertible notes due to AL-Bank $ 483,000 $ 503,000 Unsecured (b) Convertible notes with fixed conversion features, in default 895,000 895,000 Total Convertible notes $ 1,378,000 $ 1,398,000 (a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into approximately less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in the prior years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a financing institution based in Denmark. In September 2021, the Company executed a repayment agreement with AL-Bank whereby the Company shall make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in January 2025, for a total of $400,000. Once the payments are made in full in accordance with the repayment agreement, the remaining balance of $143,000 shall be forgiven and will be accounted at that time. At December 30, 2021, the outstanding balance of convertible notes payable amounted to $503,000. During the three months ended March 31, 2022, the Company made principal payments of $20,000. At March 31, 2022, the outstanding balance of the secured convertible notes payable amounted to $483,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock. (b) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into approximately less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior years. At March 31, 2022 and December 31, 2021, the outstanding balance of unsecured convertible notes payable amounted to $895,000, respectively and deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.	Note 3 - Convertible Notes Payable Convertible notes payable consisted of the following: December 31, 2021 December 31, 2020 Secured (a) Convertible notes due to AL-Bank, in default at December 31, 2020 $ 503,000 $ 543,000 Unsecured (b) Convertible notes with fixed conversion features, in default 895,000 895,000 (c) Convertible notes with adjustable conversion features, $20,000 in default at December 31, 2020 - 45,000 Total convertible notes principal outstanding 1,398,000 1,483,000 Debt discount - (14,000 ) Convertible notes, net of discount $ 1,398,000 $ 1,469,000 (a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum, matured in December 2010, convertible to common shares at a fixed conversion price of $3.25 per share, as adjusted for applicable reverse stock splits, and secured by all of the Company’s assets. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a financing institution based in Denmark. In September 2021, the Company executed a repayment agreement with AL-Bank whereby the Company shall make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in January 2025, for a total of $400,000. Once the payments are made in full in accordance with the repayment agreement, the remaining balance of $143,000 shall be forgiven and will be accounted at that time. During the year ending December 31, 2021, $40,000 was repaid relating to the agreement. At December 30, 2021 and 2020, the outstanding balance of convertible notes payable amounted to $503,000 and $543,000, respectively. (b) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits. At December 31, 2021 and 2020, the outstanding balance of convertible notes payable amounted to $895,000, respectively and is deemed in default. (c) During fiscal 2020, the Company issued convertible notes payable with adjustable conversion prices for aggregate proceeds of $803,000. The notes bear interest at 8% to 10% per annum, unsecured, and maturing between October 2020 and December 2021. At the option of the holder, the notes are convertible into shares of common stock of the Company at a price per share discount of 58% to 70% of the market price of the Company’s common stock, as defined, for 15 to 25 days preceding a conversion notice. The Company determined that the conversion options of the convertible notes were not considered indexed to the Company’s own stock and characterized the conversion features as derivative liabilities upon issuance (see Note 10). The Company also granted warrants to certain note holders to purchase 638,000 shares of the Company’s common stock. As a result, the Company recorded debt discount of $803,000, to account the fair value of the derivative liabilities of $742,000, the relative fair value of the warrants granted of $53,000 and direct fees incurred of $8,000. At December 31, 2020, the outstanding balance of the notes payable amounted to $45,000 and unamortized discount was $14,000. During the year ended December 31, 2021, the remaining notes payable of $45,000 plus unpaid interest and fees of $4,000, for a total of $49,000, were converted into 16,168,589 shares of the Company’s common stock with a fair value of $1,035,000. The Company followed the general extinguishment model to record the conversion and settlement of the debt. Notes payable, accrued interest and fees converted totaled $49,000, the related unamortized debt discount totaled ($14,000), and the derivative liability related to the conversion option of these notes, after final valuation, amounted to $382,000. The fair value of the common shares issued amounted to $1,035,000 and the difference between the total debt settled and fair value of the common shares issued amounted to $618,000 and was recorded as loss on extinguishment of debt. At December 31, 2021, the Company had no more convertible notes with adjustable conversion prices outstanding.

Convertible Notes Payable Relat

Convertible Notes Payable Related Parties	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Convertible Notes Payable Related Parties
Convertable Notes Payable - Related Parties	Note 3 - Convertible Notes Payable – Related Parties In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2022, as amended. The aggregate notes are convertible by the note holders into approximately less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior years. As of March 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $268,000. As of March 31, 2022, the convertible notes payable, including accrued interest are convertible to approximately six shares of the Company’s common stock.	Note 4 - Convertible Notes Payable – Related Parties In prior years, the Company issued unsecured convertible notes to related parties/officers in exchange for cash and/or services rendered. Certain notes payable are due to the Company’s Chief Executive Officer (CEO) and have a compounded interest rate of 8% per annum. The aggregate notes are convertible into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2020, the outstanding balance of the notes payable amounted to $298,000. During the year ended December 31, 2021, notes payable aggregating $30,000 were repaid. In addition, the CEO extended the maturity date of these convertible notes payable to December 31, 2022 with no changes to the original terms of the notes payable or any additional compensation. At December 31, 2021, the balance of convertible notes payable-related parties totaled $268,000.

Notes Payable

Notes Payable	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Notes Payable
Notes Payable	Note 4 - Notes Payable Notes payable consisted of the following: March 31, 2022 December 31, 2021 Unsecured notes (a) Notes payable- $1,639,000 - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 310,000 310,000 (c) Note payable-EID loan 150,000 150,000 Secured notes payable (d) Notes payable - in default 16,000 23,000 Total notes payable principal outstanding 2,115,000 2,122,000 Less current portion of notes payable, net of discount (1,965,000 ) (1,972,000 ) Long term notes payable $ 150,000 $ 150,000 (a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At March 31, 2022 and December 31, 2021, the outstanding balance of the notes payable was $1,639,000, respectively, and are deemed in default (b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At March 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $310,000, respectively, and are deemed in default. (c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA) under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty-four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type. Outstanding balance of the note payable as of March 31, 2022 and December 31, 2021 amounted to $150,000, respectively. The Company was in compliance with the terms of the EID loan as of March 31, 2022. (d) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 148% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one secured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2021, the outstanding balance of the secured note agreements was $23,000. During the three months ended March 31, 2022, the Company made principal payments of $7,000. At March 31, 2022, the outstanding balance of the secured notes payable was $16,000 and is deemed in default. The Company and the note holder are in negotiations to extend the due date of the note.	Note 5 - Notes Payable Notes payable consisted of the following: December 31, 2021 December 31, 2020 Unsecured notes (a) Notes payable- $1,639,000 in default $ 1,639,000 $ 1,699,000 (b) Notes payable issued by BST-in default 310,000 475,000 (c) Note payable-PPP loan - 313,000 (d) Note payable-EID loan 150,000 150,000 Secured notes payable (e) Notes payable - $23,000 in default at December 31, 2021 23,000 128,000 Total notes payable principal outstanding 2,122,000 2,765,000 Debt discount - (52,000 ) Less current portion of notes payable, net of discount (1,972,000 ) (2,250,000 ) Long term notes payable $ 150,000 $ 463,000 (a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. As of December 31, 2020, the outstanding balance of these notes payable amounted to $1,699,000 and unamortized debt discount of $52,000. During the year ended December 31, 2021, $60,000 of the notes were paid and the Company amortized the debt discount of $52,000. At December 31, 2021, the outstanding balance of the notes payable was $1,639,000 and deemed in default (b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2020, the outstanding balance of the notes payable amounted to $475,000. During the year ended December 31, 2021, $65,000 of the notes were paid, and a note holder agreed to exchange $100,000 of notes payable for 460,829 shares of the Company’s common stock with a fair value of $88,000 (see Note 12). As a result, the Company recognized a gain on extinguishment of debt of $12,000 to account for the difference between the note payable settled and fair value of the common stock issued. At December 31, 2021, the outstanding balance of the notes payable amounted to $310,000 and are deemed in default. (c) On April 7, 2020, the Company was granted a loan (the “PPP loan”) of $313,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act. The PPP loan matures on April 7, 2022, bears interest at a rate of 1% per annum, with the first nine months of interest deferred, is payable monthly commencing on October 2020, and was unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The loan term may be extended to April 7, 2025, if mutually agreed to by the Company and lender. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses. As of December 31, 2020, outstanding balance of the PPP loan amounted to $313,000. In March 2021, the Company obtained a similar PPP loan of $177,000. During the year ended December 31, 2021, the PPP loans in the aggregate of $490,000 and accrued interest of $5,000 were forgiven by the SBA and was accounted as a gain on debt extinguishment pursuant to ASC 470, Debt. As of December 31, 2021, the Company had no PPP loans outstanding. (d) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the SBA under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type. Outstanding balance of the note payable as of December 31, 2021 and 2020 amounted to $150,000, respectively. The Company was in compliance with the terms of the EID loan as of December 31, 2021. (e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 148% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one secured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2020, the outstanding balance of the secured note agreements was $128,000. During the year ended December 31, 2021, the Company made principal payments of $105,000. At December 31, 2021, the outstanding balance of the secured notes payable was $23,000 and is deemed in default. The Company and the note holder are in negotiations to extend the due date of the note.

Notes Payable Related Parties

Notes Payable Related Parties	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Notes Payable Related Parties
Notes Payable - Related Parties	Note 5 - Notes Payable – Related Party Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2022, as amended. The outstanding balance of these notes payable at March 31, 2022 and December 31, 2021 amounted to $693,000, respectively.	Note 6 - Notes Payable – Related Parties Notes payable-related parties notes represent notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum. The notes are unsecured and the outstanding balance of these notes payable at December 31, 2020 amounted to $952,000. During the year ended December 31, 2021, the Company made payments of $259,000. In addition, the CEO extended the maturity date of these notes payable to December 31, 2022 with no changes to the original terms of the notes payable or any additional compensation. At December 31, 2021, the balance of notes payable-related parties totaled $693,000 which are all due to the Company’s CEO.

Financing Obligation

Financing Obligation	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Financing Obligation
Financing Obligation	Note 6 – Financing Obligation The Company is in the process of developing Coins or Tokens which are an envisioned virtual currency. In fiscal 2018, the Company’s consolidated subsidiary BlockSafe (BST), issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined, to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000. During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe. At March 31, 2022 and December 31, 2021, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens, as defined. At March 31, 2022 and through the date of filing, BST has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At March 31, 2022, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BST, through the issuance of tokens, or through other means if tokens are never issued.	Note 7 – Financing Obligation The Company is in the process of developing Coins or Tokens which are an envisioned virtual currency. In fiscal 2018, the Company’s consolidated subsidiary BlockSafe (BST), issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined, to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000. During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe. At December 31, 2021 and 2020, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens, as defined. At December 31, 2021 and through the date of filing, BST has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At December 31, 2021, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BST, through the issuance of tokens, or through other means if tokens are never issued.

Contingent Payment Obligation

Contingent Payment Obligation	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Contingent Payment Obligation
Contingent Payment Obligation	Note 7 – Contingent Payment Obligation On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”). Under the agreement, the Company received $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against infringements of its patents. In exchange, the Funders are entitled to receive, after the payment of legal fees, the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter. The Funders shall be paid only in the event that the Company achieves recoveries of claim proceeds. At March 31, 2022 and December 31, 2021, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if claim proceeds are recovered.	Note 8 – Contingent Payment Obligation On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”). Under the agreement, the Company received $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against infringements of its patents. In exchange, the Funders are entitled to receive, after the payment of legal fees, the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter. The Funders shall be paid only in the event that the Company achieves recoveries of claim proceeds. At December 31, 2021 and 2020, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if claim proceeds are recovered.

Debt Settlement Obligation

Debt Settlement Obligation	12 Months Ended
	Dec. 31, 2021
Debt Settlement Obligation
Debt Settlement Obligation	Note 9 – Debt Settlement Obligation On May 13, 2020, the Company entered into a settlement agreement with Continuation Capital, Inc. (“Continuation”). Continuation paid $198,000 owed to Company creditors, including $140,000 of convertible debt and accrued interest due to a related party (see Note 4), $29,000 of secured notes payable and accrued interest (see Note 5) and $29,000 of accounts payable. In exchange, the Company issued 35,967,234 shares of common stock to Continuation with a fair value of $459,000. The Company accounted this transaction in accordance with ASC 480-10 and the debt settled was measured at fair value. As a result, the Company recorded a loss on debt extinguishment $261,000 to account for the difference between the carrying value of the debt settled and the fair value of the common shares issued to Continuation.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Financial Instruments
Derivative Financial Instruments	Note 10 – Derivative Financial Instruments In prior years, the Company issued convertible notes payable whose conversion shares were not explicitly limited. As a result, the Company was unable to conclude that it had enough authorized and unissued shares available to settle the conversion option. The result was that the conversion option was bifurcated from the debt host and accounted for as a derivative liability in accordance with ASC 815, and re-measured at the end of every reporting period with the change in value reported in the statement of operations. Furthermore, since the number of shares to be issued to settle the conversion option was potentially unlimited, the Company would be unable to conclude that it has sufficient authorized and available shares to satisfy other commitments to issue shares if it did not have a sequencing policy. The Company has not adopted, documented and disclosed a sequencing approach that allows its other equity linked financial instruments and conversion options to be classified as equity if they meet the requirements of ASC 815. The derivative liability was valued using the trinomial/binomial valuation method. At December 31, 2020, the balance of the derivative liabilities was $163,000. During the year ended December 31, 2021, the corresponding convertible notes payable were converted to equity (see Note 3 and 10). Pursuant to current accounting guidelines, the Company determined the final fair value of the derivative liability which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At December 31, 2021, the Company has no more instruments accounted as derivative liabilities. The fair value of the embedded derivative was determined using the following assumptions: At Extinguishment December 31, 2020 Conversion feature: Risk-free interest rate 0.08 % 0.09 % Expected volatility 424 % 495%-691 % Expected life (in years) 0.41 year 0.25 to 0.57 year Expected dividend yield - - Fair Value: Conversion feature $ 382,000 $ 163,000 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The expected volatility is based on the historical volatility of the Company’s stock. The expected life of the conversion feature of the notes was based on the remaining terms of the related notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends to its common stockholders in the past and does not expect to pay dividends to its common stockholders in the future. The following table sets forth a summary of the changes in the estimated fair value of our embedded derivative during the years ended December 31, 2021 and 2020: Year ended December 31, 2021 Year ended December 31, 2020 Fair value at beginning of year $ 163,000 $ 1,516,000 Recognition of derivative liabilities upon initial valuation - 917,000 Extinguishment of derivative liabilities (382,000 ) (3,460,000 ) Net change in the fair value of derivative liabilities 219,000 1,190,000 Fair value at end of year $ - $ 163,000

Operating Lease

Operating Lease	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Operating Lease
Operating Lease	Note 8 - Operating Lease In January 2019, the Company entered into a noncancelable operating lease for its office headquarters office requiring payments of approximately $4,000 per month, payments increasing 3% each year, and ending on January 31, 2024. We determine if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: Three months ended March 31, 2022 Three months ended March 31, 2021 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 14,000 $ 14,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the three months ended March 31, 2022 and 2021 $ 14,000 $ 14,000 Weighted average remaining lease term – operating leases (in years) 1.8 2.8 Average discount rate – operating leases 10.0 % 10.0 % The supplemental balance sheet information related to leases for the period is as follows: At March 31, 2022 Operating leases Long-term right-of-use assets $ 94,000 Short-term operating lease liabilities $ 55,000 Long-term operating lease liabilities 43,000 Total operating lease liabilities $ 98,000 Maturities of the Company’s lease liabilities are as follows: Year Ending Operating Leases 2022 (9 months) 43,000 2023 59,000 2024 5,000 Total lease payments 107,000 Less: Imputed interest/present value discount (9,000 ) Present value of lease liabilities $ 98,000 Lease expenses were $14,000 and $14,000 during the three months ended March 31, 2022 and 2021, respectively.	Note 11 - Operating Lease In January 2019, the Company entered into a noncancelable operating lease for its office headquarters requiring payments of approximately $4,000 per month, payments increasing 3% each year, and ending on January 31, 2024. We determine if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: Year ended December 31, 2021 Year ended December 31, 2020 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 56,000 $ 56,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2021 and 2020 $ 55,000 $ 55,000 Weighted average remaining lease term – operating leases (in years) 3.1 3.1 Average discount rate – operating leases 10.0 % 10.0 % The supplemental balance sheet information related to leases for the period is as follows: At December 31, 2021 Operating leases Long-term right-of-use assets $ 107,000 Short-term operating lease liabilities $ 39,000 Long-term operating lease liabilities 73,000 Total operating lease liabilities $ 112,000 Maturities of the Company’s lease liabilities are as follows: Year Ending Operating Leases 2022 58,000 2023 59,000 2024 5,000 Total lease payments 122,000 Less: Imputed interest/present value discount (10,000 ) Present value of lease liabilities $ 112,000 Lease expenses were $56,000 and $56,000 during the years ended December 31, 2021 and 2020, respectively.

Stockholders Deficit

Stockholders Deficit	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Stockholders Deficit
Stockholders' Deficit	Note 9 – Stockholders’ Deficit Common Stock During the three months ended March 31, 2022, the Company issued an aggregate of 134,853 shares of its common stock for consulting services, with a fair value of $6,000. Warrants The table below summarizes the Company’s warrant activities for the three months ended March 31, 2022: Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2022 68,981,234 0.0045-2.90 $ 0.042647 Granted - - - Canceled/Expired - - - Exercised - - - Balance, March 31, 2022 68,981,234 $ 0.0045-2.90 $ 0.042647 Balance outstanding and exercisable, March 31, 2022 68,981,234 $ 0.0045-2.90 $ 0.042647 At March 31, 2022, the intrinsic value of the warrants amounted to $464,000. The following table summarizes information concerning outstanding and exercisable warrants as of March 31, 2022: Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 13,349,242 4.00 $ 0.0045 $ 0.085 588,235 4.00 $ 0.085 $ 0.05 55,000,000 5.00 $ 0.05 $ 0.75 26,515 3.00 $ 0.75 $ 2.90 17,241 3.00 $ 2.90 $ 0.0045 - $2.90 68,981,234 4.00 $ 0.042647	Note 12 – Stockholders’ Deficit Preferred Stock On October 21, 2010, the Company amended its Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10. The designations, rights, and preferences of such preferred stock are to be determined by the Board of Directors. On November 15, 2010, the Company changed its domicile from the State of New Jersey to the State of Wyoming. In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation. The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding. The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange. In February 2014, the Company’s Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time the Company receives a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to the Company’s common stock, the minimum price discount floor level is set at $0.005, as decided by the Company’s Board of Directors. Series A Preferred Stock In 2011, the Company issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of the total issued and outstanding shares of the Company’s common stock. This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to the shareholders of the Company. The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued. Series B Preferred Stock The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange. At December 31, 2021 and 2020, there were 36,667 shares of Series B Preferred Stock outstanding. There were no issuances of Series B Preferred stock during fiscal 2021 and 2020. Common Stock During the year ended December 31, 2021, the Company issued an aggregate of 139,661,006 shares of its common stock as follows: · During the year ended December 31, 2021, pursuant to our offering under Regulation A, the Company issued 119,666,450 shares of common stock in exchange for cash of $5,368,000, net of direct fees and commission. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 55 million shares of common stock. The warrants are fully vested, exercisable at $0.05 per share and will expire in five years. · The Company issued 3,365,138 shares of its common stock for services, with a fair value of $176,000. The common shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission. · The Company issued 16,168,589 shares of common stock with a fair value of $1,035,000 upon conversion of convertible notes payable and accrued interest (see Note 3). · The Company issued 460,829 shares of common stock with a fair value of $88,000 as debt settlement (see Note 5). During the year ended December 31, 2020, the Company issued an aggregate of 712,431,992 shares of its common stock as follows: · In November 2020, the Company sold 436,337,203 shares of common stock for net proceeds of $976,000 in an offering under Regulation A. · The Company issued 6,378,671 shares of its common stock for services, with a fair value of $39,000. The common shares were valued at the respective date of issuances. · The Company issued 233,748,884 shares of common stock upon conversion of convertible notes payable and accrued interest (see Note 3). · The Company issued 35,967,234 shares of common stock upon conversion of debt settlement (see Note 9). · In December 2020, a decrease of the Company’s authorized common stock to 4,000,000,000 shares was authorized. Warrants In January and July 2020, in connection with the issuance of convertible notes that aggregated $100,000 (see Note 3) and a promissory note of $60,000 (see Note 5), the Company issued warrants to purchase 27,304,901 shares of the Company’s common stock. The warrants were exercisable immediately, at exercise prices from $0.0045 to $0.75 per share, and expire in 5 years. The warrants are classified within stockholders’ deficit, and the proceeds were allocated between the notes and warrants based on their relative fair value. The relative fair value of the warrants was determined to be $118,000 and was recorded as debt discount and additional paid-in-capital. During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost. The table below summarizes the Company’s warrant activities for the years ended December 31, 2021 and 2020: Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 100,574 $ 0.75-2.90 $ 1.1185 Granted 27,304,901 0.0045 0.0045 Canceled/Expired - - - Exercised - - - Balance, January 1, 2021 27,405,475 0.0045-2.90 0.011676 Granted 55,000,000 0.05 $ 0.05 Canceled/Expired - - - Exercised (13,424,241 ) - - Balance, December 31, 2021 68,981,234 $ 0.0045-2.90 $ 0.042114 Balance outstanding and exercisable, December 31, 2021 68,981,234 $ 0.0045-2.90 $ 0.042114 The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2021: Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 13,349,242 4.00 $ 0.0045 $ 0.085 588,235 4.00 $ 0.085 $ 0.05 55,000,000 5.00 $ 0.05 $ 0.75 26,515 3.00 $ 0.75 $ 2.90 17,241 3.00 $ 2.90 $ 0.0045 - $2.90 68,981,234 4.00 $ 0.042114

Stock Options

Stock Options	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Stock Options
Stock Options	Note 10 – Stock Options The table below summarizes the Company’s stock option activities for the three months ended March 31, 2022: Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2022 83,133,001 0.005- 1,121,250,000 $ 0.0274 Granted - - - Exercised - - - Expired - - - Balance outstanding, March 31, 2022 83,133,001 $ 0.005- 1,121,250,000 $ 0.0274 Balance exercisable, March 31, 2022 53,433,547 $ 0.005- 1,121,250,000 $ 0.0274 At March 31, 2022, the intrinsic value of outstanding options was $717,000. During the period ended March 31, 2022, the Company recognized stock compensation expense of $1,636,000 to account the fair value of stock options that vested. As of March 31, 2022, fair value of unvested stock options amounted to $1.3 million and will be recognized as stock compensation expense in future periods as it vests. The following table summarizes information concerning the Company’s stock options as of March 31, 2022: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 2 $ 1,121,250,000 1 1 $ 1,121,250,000 $ 2.85 126,000 7 2.85 126,000 6 2.85 $ 3.125 392,000 6 3.125 392,000 5 3.125 $ 2.05 115,000 9 2.05 115,000 8 2.05 $ 0.0375 65,000,000 10 0.0375 36,748,634 10 0.0375 $ 0.005 17,500,000 10 0.005 16,051,912 10 0.005 $ 0.005 – 1,121,250,000 83,133,001 6.8 $ 0.03704 53,433,547 6.8 $ 0.0274	Note 13 – Stock Options In November 2012, the stockholders approved the 2012 Stock Option Plan for the Company’s employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000 and was increased to 400,000,000 in November 2017 by unanimous consent of the Board of Directors. During the year ended December 31, 2020, the Company granted options to purchase an aggregate of 57,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share, vest over six months, and expire in 10 years, with a total fair value of approximately $3,853,000 using the Black-Scholes Merton option pricing model. The fair value of the options was determined using a Black-Scholes Merton option pricing model based on the following assumptions: (i) volatility rate of 604%, (ii) discount rate of 0.95%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $506,000 to account the fair value of options that vested during the period. As of December 31, 2020, the unamortized stock compensation amounted to approximately $3.6 million which was recognized in fiscal 2021. In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense. During the year ended December 31, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company also issued 39,955,655 shares of the Company’s common stock upon cashless exercise of 42,500,000 options. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share for 2,500,000 option shares and $0.0375 for 65,000,000 option shares, vest over six months, and expire in 10 years, with a total fair value of approximately $5,400,000 using the Black-Scholes Merton Option Pricing model. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 137%, (ii) discount rate of 1.46%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $368,000 to account for the fair value of options that vested during the period. As of December 31, 2021, the unamortized stock compensation amounted to approximately $5,032,000 which will be recognized in fiscal 2022. The table below summarizes the Company’s stock option activities for the period January 1, 2020 to December 31, 2021: Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 633,001 $ 2.05-1,121,250,000 $ 2.93 Granted 57,500,000 0.0005 0.0005 Exercised - - - Expired - - - Balance, December 31, 2020 58,133,001 0.0005-1,121,250,000 0.03704 Granted 67,500,000 0.005-0.0375 0.0104 Exercised (42,500,000 ) - - Expired - - - Balance outstanding, December 31, 2021 83,133,001 $ 0.005-1,121,250,000 $ 0.0274 Balance exercisable, December 31, 2021 20,236,826 $ 0.005-1,121,250,000 $ 0.0274 The following table summarizes information concerning the Company’s stock options as of December 31, 2021: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 2 $ 1,121,250,000 1 1 $ 1,121,250,000 $ 2.85 126,000 7 2.85 126,000 6 2.85 $ 3.125 392,000 6 3.125 392,000 5 3.125 $ 2.05 115,000 9 2.05 115,000 8 2.05 $ 0.0375 65,000,000 0.0375 3,551,913 10 0.0375 $ 0.005 17,500,000 10 0.005 16,051,912 10 0.005 $ 0.005 – 1,121,250,000 83,133,001 6.8 $ 0.03704 20,236,826 6.8 $ 0.0274

Income Tax Provision

Income Tax Provision	12 Months Ended
	Dec. 31, 2021
Income Tax Provision
Income Tax Provision	Note 14 - Income Tax Provision A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows for the year ended: December 31, 2021 December 31, 2020 Federal statutory income tax rate 21.0 % 21.0 % State tax, net of federal benefit 7.0 % 5.0 % Change in valuation allowance on net operating loss carry-forwards (28.0 ) (26.0 ) Effective income tax rate 0.0 % 0.0 % Deferred tax assets consist of the following: December 31, 2021 December 31, 2020 Net deferred tax assets: Stock-based compensation $ 2,698,000 $ 702,000 Private placement costs 394,000 366,000 Operating lease liability 31,000 42,000 Loss on extinguishment of debt 1,858,000 1,697,000 Net operating loss carryforwards 6,494,000 5,946,000 Deferred tax assets 11,475,000 8,753,000 Less valuation allowance (11,475,000 ) (8,753,000 ) The provisions of ASC Topic 740, Accounting for Income Taxes, require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2021 and 2020, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was more likely than not that the net deferred tax assets were not fully realizable. Accordingly, the Company established a full valuation allowance against its net deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance. At December 31, 2021 and 2020, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal NOL purposes approximately $23.0 million and $21.4 million was available at December 31, 2021 and 2020. For state NOL purposes approximately $9.8 million and $12.5 million was available at December 31, 2021 and 2020, respectively. The Federal carryforwards expire on various dates through 2040 and the state carryforwards expire through 2040. Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation. The Company’s operations are based in New Jersey and it is subject to Federal and New Jersey state income tax. Tax years after 2015 are open to examination by United States and state tax authorities. The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. ASC 740 also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions. As of December 31, 2021 and 2020, no liability for unrecognized tax benefits was required to be recorded or disclosed. and $, respectively.

Subsequent Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Subsequent Events
Subsequent Events	Note 11 – Subsequent Events   Subsequent to March 31, 2022, the Company issued 96,083 shares of common stock for services with a fair value of $4,000.   In May 2022, the Company amended the exercise price of 50 million shares of stock warrants granted in September 2021 from $0.05 per share to $0.02 per share.  As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $1,000,000.  As an inducement to these warrant holders to exercise their warrants, the Company granted them stock warrants to purchase 50 million shares of common stock.  The warrants are exercisable at $0.05 per share and will expire in 5 years. The Company is in the process of determining the appropriate accounting for these transactions.   In May 2022, a warrant holder agreed to extinguish a total of 605,476 warrant shares, relating to warrant agreements dated November 21, 2019 and July 27, 2020, in exchange for a one-time payment from the Company in the amount of $165,000.   In May 2022, the Company issued 5,000,000 shares of common stock for services with a fair value of $104,000.   In June 2022, the Company issued 2,500,000 shares of common stock for services with a fair value of $56,000.   On June 14, 2022, the Board of Directors and holders of a majority of the voting shareholders approved a resolution to change the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc.	Note 11 – Subsequent Events Subsequent to March 31, 2022, the Company issued 96,083 shares of common stock for services with a fair value of $4,000. In May 2022, the Company amended the exercise price of 50 million shares of stock warrants granted in September 2021 from $0.05 per share to $0.02 per share. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $1,000,000. As an inducement to these warrant holders to exercise their warrants, the Company granted them stock warrants to purchase 50 million shares of common stock. The warrants are exercisable at $0.05 per share and will expire in 5 years. The Company is in the process of determining the appropriate accounting for these transactions. In May 2022, a warrant holder agreed to extinguish a total of 605,476 warrant shares, relating to warrant agreements dated November 21, 2019 and July 27, 2020, in exchange for a one-time payment from the Company in the amount of $165,000. In May 2022, the Company issued 5,000,000 shares of common stock for services with a fair value of $104,000. In June 2022, the Company issued 2,500,000 shares of common stock for services with a fair value of $56,000. On June 14, 2022, the Board of Directors and holders of a majority of the voting shareholders approved a resolution to change the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc. Note 15 – Subsequent Events Subsequent to December 31, 2021, the Company issued 134,853 shares of common stock for services with a fair value of $6,000.

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies
Concentrations	Concentrations For the three months ended March 31, 2022, sales to four customers comprised 38%, 26%, 11% and 10% of revenues. For the three months ended March 31, 2021, sales to two customers comprised 72% and 15% of revenues. At March 31, 2022, two customers comprised 59% and 18% of accounts receivable. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At March 31, 2022, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.	For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. For the year ended December 31, 2020, sales to two customers comprised 72% and 15% of revenues, respectively. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively. At December 31, 2020, three customers comprised 50%, 24% and 10% of accounts receivable, respectively. The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At December 31, 2021, the Company had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.
Segments	Segments The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.	The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.	In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
Basis of presentation and principles of consolidation	Basis of presentation and principles of consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been included. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2022. These financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2021 and notes thereto contained in the Annual Report on Form 10-K of the Company as filed with the SEC on April 14, 2022. The condensed consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. At March 31, 2022, noncontrolling interests represents 51% of BST that the Company does not directly own. The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years. The management fee is eliminated in consolidation. At March 31, 2022 and December 31, 2021, the amount of VIE cash on the accompanying condensed consolidated balance sheets can be used only to settle obligations of BST, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the general credit of the Company.	The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. At December 31, 2021, noncontrolling interests represents 51% of BST that the Company does not directly own. The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years. The management fee is eliminated in consolidation. At December 31, 2021 and 2020, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the general credit of the Company.
Going Concern	Going Concern We have yet to establish any history of profitable operations. During the three months ended March 31, 2022, the Company incurred a net loss of $2,867,000 and used cash in operating activities of $1,060,000, and at March 31, 2022, the Company had a stockholders’ deficit of $12,814,000. In addition, we are in default on notes payable and convertible notes payable in the aggregate amount of $2,861,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report published on our December 31, 2021 year-end financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern. Management estimates that the current funds on hand will be sufficient to continue operations through the next six months. Our ability to continue as a going concern is dependent upon our ability to continue to implement our business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of its strategy to increase revenues, there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon our ability to increase our customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.	The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the year ended December 31, 2021, the Company incurred a net loss of $17,245,000 and used cash in operating activities of $3,063,000 and at December 31, 2021, the Company had a stockholders’ deficit of $11,589,000. Also, at December 31, 2021, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,867,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. At December 31, 2021, the Company had cash on hand in the amount of $2,084,000. Management estimates that the current funds on hand will be sufficient to continue operations through the next twelve months. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While the Company believes in the viability of its strategy to increase revenues, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing.
COVID-19	COVID-19 In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally. It has also disrupted the normal operations of many businesses. This outbreak could decrease spending, adversely affect demand for the Company’s products, and harm the Company’s business and results of operations. During the three months ended March 31, 2022 and the year ended December 31, 2021, the Company believes the COVID-19 pandemic did impact its operating results. For the three months ended March 31, 2022 and the year ended December 31, 2021, sales to customers decreased by 30% and 7%, respectively, as compared to the prior year. However, the Company has not observed any impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. At this time, it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.	In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally. It has also disrupted the normal operations of many businesses. This outbreak could decrease spending, adversely affect demand for the Company’s products, and harm the Company’s business and results of operations. During the years ended December 31, 2021 and 2020, the Company believes the COVID-19 pandemic did impact its operating results. For the years ended December 31, 2021 and 2020, sales to customers decreased by 7% and 73%, respectively, as compared to the prior year. However, the Company has not observed any impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. At this time, it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.
Revenue Recognition	The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust® and SafeVchat™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Three months ended March 31, 2022 March 31, 2021 Software $ 32,000 $ 45,000 Service - 1,000 Total revenue $ 32,000 $ 46,000	The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust® and SafeVchat™ products. The Company usually recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining customer contracts. Cost of revenue includes direct costs and fees related to the sale of our products. The following tables present our revenue disaggregated by major product and service lines: Year ended December 31, 2021 December 31, 2020 Software $ 193,000 $ 200,000 Service - 7,000 Total revenue $ 193,000 $ 207,000
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.	The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The Company is required to use of observable market data if such data is available without undue cost and effort. The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments. As of December 31, 2020, the Company’s balance sheet includes Level 2 liabilities comprised of the fair value of embedded derivative liabilities of $163,000 (see Note 10).
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. All outstanding derivative financial instruments were extinguished during fiscal year 2021.	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton option pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.	The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.
Loss per Share	Loss per Share Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Three months ended March 31, 2022 March 31, 2021 Options to purchase common stock 83,133,001 40,633,001 Warrants to purchase common stock 68,981,234 27,355,475 Convertible notes 21 21 Convertible Series B Preferred stock 1,284,394 492,455 Total 153,398,650 68,480,952	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: Year ended December 31, 2021 December 31, 2020 Options to purchase common stock 83,133,001 58,133,001 Warrants to purchase common stock 68,981,234 27,405,476 Convertible notes 21 1,156,304 Convertible Series B Preferred stock 1,255,638 791,170 Total 153,369,894 87,485,950
Reverse Stock Split		On June 25, 2020, the Company completed a 1:500 reverse stock split of the Company’s issued and outstanding shares of common stock and all fractional shares were rounded up. All share and per share amounts in the accompanying financial statements have been adjusted retroactively to reflect the reverse stock split as if it had occurred at the beginning of the earliest period presented.
Accounts Receivable		Accounts receivable consist of trade amounts due from customers, and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2021 and 2020, the allowance for doubtful accounts was $20,000 and $20,000, respectively.
Property and Equipment		Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows: Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7 Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2021 and 2020, the Company did not recognize any impairment for its property and equipment.
Impairment of Long-lived Assets		The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, including intangible assets other than goodwill, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2021 and 2020, the Company had no impairment of long-lived assets.
Income Taxes		The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Leases		We lease our corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 11).
Advertising, Sales and Marketing Costs		Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2021 and 2020, advertising, sales and marketing expenses were $103,000 and $2,000, respectively.
Research and Development Costs		Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products comprise research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2021 and 2020, research and development costs were $566,000 and $520,000, respectively.

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies
Schedule of Revenue Recognition	Three months ended March 31, 2022 March 31, 2021 Software $ 32,000 $ 45,000 Service - 1,000 Total revenue $ 32,000 $ 46,000	Year ended December 31, 2021 December 31, 2020 Software $ 193,000 $ 200,000 Service - 7,000 Total revenue $ 193,000 $ 207,000
Schedule of earning per share	Three months ended March 31, 2022 March 31, 2021 Options to purchase common stock 83,133,001 40,633,001 Warrants to purchase common stock 68,981,234 27,355,475 Convertible notes 21 21 Convertible Series B Preferred stock 1,284,394 492,455 Total 153,398,650 68,480,952	Year ended December 31, 2021 December 31, 2020 Options to purchase common stock 83,133,001 58,133,001 Warrants to purchase common stock 68,981,234 27,405,476 Convertible notes 21 1,156,304 Convertible Series B Preferred stock 1,255,638 791,170 Total 153,369,894 87,485,950
Schedule of Property and Equipment		Estimated Useful Life (Years) Computer equipment 5 Computer software 3 Furniture and fixture 7 Office equipment 7

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property and Equipment
Schedule of property and equipment, stated at cost, less accumulated depreciation	December 31, 2021 December 31, 2020 Computer equipment $ 82,000 $ 82,000 Computer software 44,000 44,000 Furniture and fixtures 10,000 10,000 Office equipment 17,000 17,000 153,000 153,000 Less accumulated depreciation (153,000 ) (151,000 ) $ - $ 2,000

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Convertible Notes Payable (Tables)
Schedule of convertible notes payable	March 31, 2022 December 31, 2021 Secured (a) Convertible notes due to AL-Bank $ 483,000 $ 503,000 Unsecured (b) Convertible notes with fixed conversion features, in default 895,000 895,000 Total Convertible notes $ 1,378,000 $ 1,398,000	December 31, 2021 December 31, 2020 Secured (a) Convertible notes due to AL-Bank, in default at December 31, 2020 $ 503,000 $ 543,000 Unsecured (b) Convertible notes with fixed conversion features, in default 895,000 895,000 (c) Convertible notes with adjustable conversion features, $20,000 in default at December 31, 2020 - 45,000 Total convertible notes principal outstanding 1,398,000 1,483,000 Debt discount - (14,000 ) Convertible notes, net of discount $ 1,398,000 $ 1,469,000

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Notes Payable (Tables)
Schedule of notes payable	March 31, 2022 December 31, 2021 Unsecured notes (a) Notes payable- $1,639,000 - in default $ 1,639,000 $ 1,639,000 (b) Notes payable issued by BST - in default 310,000 310,000 (c) Note payable-EID loan 150,000 150,000 Secured notes payable (d) Notes payable - in default 16,000 23,000 Total notes payable principal outstanding 2,115,000 2,122,000 Less current portion of notes payable, net of discount (1,965,000 ) (1,972,000 ) Long term notes payable $ 150,000 $ 150,000	December 31, 2021 December 31, 2020 Unsecured notes (a) Notes payable- $1,639,000 in default $ 1,639,000 $ 1,699,000 (b) Notes payable issued by BST-in default 310,000 475,000 (c) Note payable-PPP loan - 313,000 (d) Note payable-EID loan 150,000 150,000 Secured notes payable (e) Notes payable - $23,000 in default at December 31, 2021 23,000 128,000 Total notes payable principal outstanding 2,122,000 2,765,000 Debt discount - (52,000 ) Less current portion of notes payable, net of discount (1,972,000 ) (2,250,000 ) Long term notes payable $ 150,000 $ 463,000

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Financial Instruments
Schedule of derivative liability	At Extinguishment December 31, 2020 Conversion feature: Risk-free interest rate 0.08 % 0.09 % Expected volatility 424 % 495%-691 % Expected life (in years) 0.41 year 0.25 to 0.57 year Expected dividend yield - - Fair Value: Conversion feature $ 382,000 $ 163,000
Summary of changes in derivative liabilities	Year ended December 31, 2021 Year ended December 31, 2020 Fair value at beginning of year $ 163,000 $ 1,516,000 Recognition of derivative liabilities upon initial valuation - 917,000 Extinguishment of derivative liabilities (382,000 ) (3,460,000 ) Net change in the fair value of derivative liabilities 219,000 1,190,000 Fair value at end of year $ - $ 163,000

Operating Lease (Tables)

Operating Lease (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Operating Lease
Schedule of lease expense and supplemental cash flow information	Three months ended March 31, 2022 Three months ended March 31, 2021 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 14,000 $ 14,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the three months ended March 31, 2022 and 2021 $ 14,000 $ 14,000 Weighted average remaining lease term – operating leases (in years) 1.8 2.8 Average discount rate – operating leases 10.0 % 10.0 %	Year ended December 31, 2021 Year ended December 31, 2020 Lease Cost Operating lease cost (included in general and administration in the Company’s statement of operations) $ 56,000 $ 56,000 Other Information Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2021 and 2020 $ 55,000 $ 55,000 Weighted average remaining lease term – operating leases (in years) 3.1 3.1 Average discount rate – operating leases 10.0 % 10.0 %
Schedule of supplemental balance sheet information	At March 31, 2022 Operating leases Long-term right-of-use assets $ 94,000 Short-term operating lease liabilities $ 55,000 Long-term operating lease liabilities 43,000 Total operating lease liabilities $ 98,000	At December 31, 2021 Operating leases Long-term right-of-use assets $ 107,000 Short-term operating lease liabilities $ 39,000 Long-term operating lease liabilities 73,000 Total operating lease liabilities $ 112,000
Schedule of maturities	Year Ending Operating Leases 2022 (9 months) 43,000 2023 59,000 2024 5,000 Total lease payments 107,000 Less: Imputed interest/present value discount (9,000 ) Present value of lease liabilities $ 98,000	Year Ending Operating Leases 2022 58,000 2023 59,000 2024 5,000 Total lease payments 122,000 Less: Imputed interest/present value discount (10,000 ) Present value of lease liabilities $ 112,000

Stockholders Deficit (Tables)

Stockholders Deficit (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Stockholders Deficit
Schedule of stock warrants activity	Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2022 68,981,234 0.0045-2.90 $ 0.042647 Granted - - - Canceled/Expired - - - Exercised - - - Balance, March 31, 2022 68,981,234 $ 0.0045-2.90 $ 0.042647 Balance outstanding and exercisable, March 31, 2022 68,981,234 $ 0.0045-2.90 $ 0.042647	Number of Warrant Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 100,574 $ 0.75-2.90 $ 1.1185 Granted 27,304,901 0.0045 0.0045 Canceled/Expired - - - Exercised - - - Balance, January 1, 2021 27,405,475 0.0045-2.90 0.011676 Granted 55,000,000 0.05 $ 0.05 Canceled/Expired - - - Exercised (13,424,241 ) - - Balance, December 31, 2021 68,981,234 $ 0.0045-2.90 $ 0.042114 Balance outstanding and exercisable, December 31, 2021 68,981,234 $ 0.0045-2.90 $ 0.042114
Schedule of warrants outstanding and exercisable	Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 13,349,242 4.00 $ 0.0045 $ 0.085 588,235 4.00 $ 0.085 $ 0.05 55,000,000 5.00 $ 0.05 $ 0.75 26,515 3.00 $ 0.75 $ 2.90 17,241 3.00 $ 2.90 $ 0.0045 - $2.90 68,981,234 4.00 $ 0.042647	Warrants Outstanding and Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 0.0045 13,349,242 4.00 $ 0.0045 $ 0.085 588,235 4.00 $ 0.085 $ 0.05 55,000,000 5.00 $ 0.05 $ 0.75 26,515 3.00 $ 0.75 $ 2.90 17,241 3.00 $ 2.90 $ 0.0045 - $2.90 68,981,234 4.00 $ 0.042114

Stock Options (Tables)

Stock Options (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Stock Options (Tables)
Schedule of stock options plan	Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2022 83,133,001 0.005- 1,121,250,000 $ 0.0274 Granted - - - Exercised - - - Expired - - - Balance outstanding, March 31, 2022 83,133,001 $ 0.005- 1,121,250,000 $ 0.0274 Balance exercisable, March 31, 2022 53,433,547 $ 0.005- 1,121,250,000 $ 0.0274	Number of Options Shares Exercise Price Range Per Share Weighted Average Exercise Price Balance, January 1, 2020 633,001 $ 2.05-1,121,250,000 $ 2.93 Granted 57,500,000 0.0005 0.0005 Exercised - - - Expired - - - Balance, December 31, 2020 58,133,001 0.0005-1,121,250,000 0.03704 Granted 67,500,000 0.005-0.0375 0.0104 Exercised (42,500,000 ) - - Expired - - - Balance outstanding, December 31, 2021 83,133,001 $ 0.005-1,121,250,000 $ 0.0274 Balance exercisable, December 31, 2021 20,236,826 $ 0.005-1,121,250,000 $ 0.0274
Schedule of stock option outstanding and exercisable	Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 2 $ 1,121,250,000 1 1 $ 1,121,250,000 $ 2.85 126,000 7 2.85 126,000 6 2.85 $ 3.125 392,000 6 3.125 392,000 5 3.125 $ 2.05 115,000 9 2.05 115,000 8 2.05 $ 0.0375 65,000,000 10 0.0375 36,748,634 10 0.0375 $ 0.005 17,500,000 10 0.005 16,051,912 10 0.005 $ 0.005 – 1,121,250,000 83,133,001 6.8 $ 0.03704 53,433,547 6.8 $ 0.0274	Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price $ 1,121,250,000 1 2 $ 1,121,250,000 1 1 $ 1,121,250,000 $ 2.85 126,000 7 2.85 126,000 6 2.85 $ 3.125 392,000 6 3.125 392,000 5 3.125 $ 2.05 115,000 9 2.05 115,000 8 2.05 $ 0.0375 65,000,000 0.0375 3,551,913 10 0.0375 $ 0.005 17,500,000 10 0.005 16,051,912 10 0.005 $ 0.005 – 1,121,250,000 83,133,001 6.8 $ 0.03704 20,236,826 6.8 $ 0.0274

Income Tax Provision (Tables)

Income Tax Provision (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Provision
Schedule of reconcilliation of fedral statutory income tax rate	December 31, 2021 December 31, 2020 Federal statutory income tax rate 21.0 % 21.0 % State tax, net of federal benefit 7.0 % 5.0 % Change in valuation allowance on net operating loss carry-forwards (28.0 ) (26.0 ) Effective income tax rate 0.0 % 0.0 %
Schedule of deferred tax assets and liabilities	December 31, 2021 December 31, 2020 Net deferred tax assets: Stock-based compensation $ 2,698,000 $ 702,000 Private placement costs 394,000 366,000 Operating lease liability 31,000 42,000 Loss on extinguishment of debt 1,858,000 1,697,000 Net operating loss carryforwards 6,494,000 5,946,000 Deferred tax assets 11,475,000 8,753,000 Less valuation allowance (11,475,000 ) (8,753,000 )

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Revenue	$ 32,000	$ 46,000	$ 193,000	$ 207,000
Service [Member]
Revenue	0	1,000	0	7,000
Software [Member]
Revenue	$ 32,000	$ 45,000	$ 193,000	$ 200,000

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2021
Office equipment [Member]
Estimated Useful Life (Years)	7 years
Computer equipment [Member]
Estimated Useful Life (Years)	5 years
Computer software [Member]
Estimated Useful Life (Years)	3 years
Furniture and fixtures [Member]
Estimated Useful Life (Years)	7 years

Organization and Summary of S_6

Organization and Summary of Significant Accounting Policies (Details 2) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Organization and Summary of Significant Accounting Policies
Options to purchase common stock	83,133,001	40,633,001	83,133,001	58,133,001
Warrants to purchase common stock	68,981,234	27,355,475	68,981,234	27,405,476
Convertible notes	21	21	21	1,156,304
Convertible Series B Preferred stock	1,284,394	492,455	1,255,638	791,170
Total	153,398,650	68,480,952	153,369,894	87,485,950

Organization and Summary of S_7

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Jun. 25, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Net cash used in operating activities		$ (1,060,000)	$ (585,000)	$ (3,063,000)	$ (2,256,000)
Percentage of sales decreased during period		30%		7%	73%
Total Stockholders' Deficit		$ (12,814,000)		$ (11,589,000)
Notes payable aggregate amount		2,861,000		2,867,000
FDIC insured limit		250,000		250,000
Net loss		(2,867,000)	(9,946,000)	(17,245,000)	$ (10,088,000)
Research and development costs		154,000	$ 145,000	566,000	520,000
Cash		$ 974,000		2,084,000	162,000
Allowance for doubtful debts				20,000	20,000
Derivative liabilities				0	163,000
Reverse stock split	On June 25, 2020, the Company completed a 1:500 reverse stock split of the Company’s
Advertising, sales and marketing costs				$ 103,000	$ 2,000
One customer [Member] | Revenues [Member]
Concentration Risk, Percentage		38%	72%	36%
One customer [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage		59%		65%	50%
Two customer [Member] | Revenues [Member]
Concentration Risk, Percentage		26%	15%	32%
Two customer [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage		18%		14%	24%
Three customer [Member] | Revenues [Member]
Concentration Risk, Percentage		11%		19%
Three customer [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage					10%
BST [Member]
Ownership interest held by company		49%		49%
Ownership interest held by three executive officers		31%		31%
Noncontrolling interest percentage		51%		51%
Management fee per month		$ 36,000		$ 36,000
Financing milestone reached amount		1,000,000		1,000,000
Additional management fee owed amount		$ 5,000,000		$ 5,000,000
Management fee description		The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years		The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property and equipment gross		$ 153,000	$ 153,000
Less accumulated depreciation		(153,000)	(151,000)
Property and equipment net	$ 24,000	0	2,000
Office equipment [Member]
Property and equipment gross		17,000	17,000
Computer equipment [Member]
Property and equipment gross		82,000	82,000
Computer software [Member]
Property and equipment gross		44,000	44,000
Furniture and fixtures [Member]
Property and equipment gross		$ 10,000	$ 10,000

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property and Equipment
Depreciation expense	$ 2,000	$ 4,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Secured
(a) Convertible notes due to AL-Bank, in default at December 31, 2020	$ 483,000	$ 503,000	$ 543,000
Unsecured
(b) Convertible notes with fixed conversion features, in default	895,000	895,000	895,000
Convertible notes, net of discount	$ 1,378,000	1,398,000	1,469,000
(c) Convertible notes with adjustable conversion features, $20,000 in default at December 31, 2020		0	45,000
Total convertible notes principal outstanding		1,398,000	1,483,000
Debt discount		$ 0	$ (14,000)

Convertible Notes Payable (De_2

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Principal payments	$ 20,000
(a) DART/Citco Global, in default	503,000		$ 543,000	$ 543,000
Unamortized debt discount				$ 14,000
Fair value of the warrants			53,000
Maturity date description				maturing between October 2020 and December 2021
Fair value of warrant granted			$ 2,657,000
Warrants issued to purchase common shares			638,000
Fair value of derivative liabilities			$ 742,000
Direct fees			8,000
Convertible notes payable, outstanding balance	1,378,000		1,398,000	$ 1,469,000
Proceeds from convertible notes payable			0	803,000
Private placement costs			0	(175,000)
Repayment of convertible notes	$ 20,000	$ 0	$ 40,000	43,000
Unsecured Convertible Notes Payable [Member]
Private placement costs				$ 803,000
Interest rate decriptions				The notes bear interest at 8% to 10% per annum
Conversion description				At the option of the holder, the notes are convertible into shares of common stock of the Company at a price per share discount of 58% to 70% of the market price of the Company’s common stock, as defined, for 15 to 25 days preceding a conversion notice
2005 Through 2007 [Member]
Maturity date description	due on various dates from March 2008 to March 2015		due on various dates from March 2008 to March 2015, and are currently in default
Convertible notes payable, outstanding balance	$ 895,000		$ 895,000	$ 895,000
Proceeds from convertible notes payable	$ 895,000		$ 895,000
Interest rate decriptions	notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum		The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum
2005 [Member]
(a) DART/Citco Global, in default	$ 483,000		$ 503,000	543,000
Interest rate	7.50%		7.50%
Total	$ 400,000		$ 400,000
Monyhly payment	10,000		10,000
Remaining balance	$ 143,000		$ 143,000
Conversion price			$ 3.25
Repayment of convertible notes			$ 40,000
Convertible Notes Payable [Member]
Unamortized debt discount			14,000
Convertible notes payable, outstanding balance			45,000	$ 45,000
Unpaid interest fees			$ 4,000
Common stock shares issued upon conversion of debt			16,168,589
Debt instrument converted amount, shares issued			1
Debt instrument converted amount, value			$ 1,035,000
Debt instrument converted amount, principal			1,035,000
Loss on extinguishment of debt			618,000
Debt instrument, accrued interest			49,000
Initial fair value of the embedded conversion feature			$ 382,000

Convertible Notes Payable Rel_2

Convertible Notes Payable Related Parties (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Convertible notes payable - related parties	$ 268,000	$ 268,000	$ 298,000
Repayment of convertible notes payable-related parties		30,000
Chief Executive Officer [Member]
Convertible notes payable - related parties	$ 268,000	$ 268,000
Debt Conversion, Converted Instrument, Rate	8%	8%

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Notes Payable Related Parties
(a) Notes payable- $1,639,000 in default	$ 1,639,000	$ 1,639,000	$ 1,699,000
(b) Notes payable issued by BST-in default	310,000	310,000	475,000
(c) Note payable-EID loan	150,000	150,000	150,000
Unsecured notes payable-in default
(d)Notes payable-in default	16,000	23,000	128,000
Total notes payable principal outstanding	2,115,000	2,122,000	2,765,000
Less current portion of notes payable	(1,965,000)	(1,972,000)	(2,250,000)
Long term notes payable	$ 150,000	150,000	463,000
(c) Note payable-PPP loan		0	313,000
Secured notes payable
Debt discount		$ 0	$ (52,000)

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended	12 Months Ended
	May 15, 2020	Apr. 07, 2020	Mar. 31, 2021	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Notes payable, outstanding balance				$ 310,000	$ 310,000	$ 475,000
Note payable default					460,829
Aggregate amount of paycheck protection		$ 313,000				$ 313,000
Forgiven aggregate amount of paycheck protection					$ 490,000
Gain on extinguish of PPP					12,000
Notes payable exchanged					100,000
Proceeds from loan			$ 177,000
Amount payable					105,000
Forgiven accrued interest on PPP					5,000
PPP maturity date						Apr. 07, 2025
PPP interest rate						1%
Notes payable, outstanding balance				16,000	23,000	$ 128,000
Long term notes payable				150,000	150,000	463,000
Unamortized debt discount						14,000
Notes payable in default				1,639,000	1,639,000	1,699,000
EID Loan [Member]
Notes payable, outstanding balance				150,000	150,000
Loan borrowed amount	$ 150,000
Interest rate on loan	3.75%
Monthly payment on loan, description	Monthly principal and interest payments of $250 per month
Notes Payable [Member]
Notes payable, outstanding balance				$ 1,639,000	$ 1,639,000	1,699,000
Interest rate decriptions				The notes are unsecured, bear interest at a rate of 8% through 14% per annum	The notes are unsecured, bear interest at a rate of 8% through 14% per annum
Obligation on debt settlement					$ 60,000
Unamortized debt discount						52,000
Notes payable in default					1,639,000
Amortized debt discount					52,000
One Note [Member]
Amount payable				$ 7,000
Notes payable, outstanding balance				$ 16,000	23,000	128,000
Secured notes payable					21,000	$ 21,000
Note issued					$ 88,000		$ 468,000
Interest rate of notes					148%	148%	8%
Principal amount					$ 319,000	$ 319,000

Notes Payable Related Parties (

Notes Payable Related Parties (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Notes payable - related parties	$ 693,000		$ 693,000	$ 952,000
Repayment of notes payable-related parties	$ 0	$ 260,000	$ 259,000	54,000
Chief Executive Officer [Member]
Due date	Dec. 31, 2022		Dec. 31, 2022
Repayment of notes payable-related parties			$ (259,000)	$ (54,000)
Chief Executive Officer [Member] | Maximum [Member]
Interest rate				0%
Chief Executive Officer [Member] | Minimum [Member]
Interest rate				10%
Chief Executive Officer [Member] | Maximum [Member]
Interest rate	0%
Chief Executive Officer [Member] | Minimum [Member]
Interest rate	10%

Financing Obligation (Details N

Financing Obligation (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020
Financing obligation	$ 1,263,000	$ 1,263,000			$ 1,263,000
Promissory note - various parties [Member] | Related Party [Member]
Financing obligation			$ 315,000
Tokens issued to unrelated parties			$ 122,000
Unsecured Convertible Notes Payable [Member]
Tokens issued to unrelated parties				$ 50,000
Promissory note issued to unrelated parties				$ 776,000
BST [Member]
Financing obligation	$ 1,263,000	$ 1,263,000			$ 1,263,000
Financing obligation description	as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100%	as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100%

Contingent Payment Obligation (

Contingent Payment Obligation (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Sep. 06, 2017	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Contingent payment obligation		$ 1,500,000	$ 1,500,000	$ 1,500,000	$ 1,500,000
Litigation funding agreement [Member] | Therium Inc. and VGL Capital, LLC [Member]
Contingent payment obligation	$ 1,500,000
Gross proceeds	$ 1,500,000
Contingent obligation, description	the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter

Debt Settlement Obligation (Det

Debt Settlement Obligation (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			$ 0	$ 198,000
Proceeds from issuance of common stock	$ 0	$ 1,449,000	5,368,000	976,000
loss on extinguishment of debt	$ 0	$ 607,000	112,000	$ 4,841,000
May 13, 2020 [Member] | Continuation Capital, Inc [Member]
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			$ 198,000
Common stock shares issued during the period for settlement			35,967,234
Proceeds from issuance of common stock			$ 459,000
loss on extinguishment of debt			261,000
May 13, 2020 [Member] | Continuation Capital, Inc [Member] | Convertible Debt [Member]
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			140,000
May 13, 2020 [Member] | Continuation Capital, Inc [Member] | Secured notes payable [Member]
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			29,000
Accounts Payable [Member] | May 13, 2020 [Member] | Continuation Capital, Inc [Member]
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation			$ 29,000

Derivative Financial Instrume_3

Derivative Financial Instruments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Risk-free interest rate	0.08%	0.09%
Expected dividend yield	0%	0%
Expected volatility	424%
Expected life (in years)	4 months 28 days
Fair Value:
Conversion feature	$ 382,000	$ 163,000
Maximum [Member]
Expected volatility		691%
Expected life (in years)		6 months 25 days
Minimum [Member]
Expected volatility		495%
Expected life (in years)		3 months

Derivative Financial Instrume_4

Derivative Financial Instruments (Details 1) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Debt Settlement Obligation (Details Narrative)
Fair value at beginning of period	$ 0	$ 163,000	$ 163,000	$ 1,516,000
Recognition of derivative liabilities upon initial valuation			0	917,000
Extinguishment of derivative liabilities			(382,000)	(3,460,000)
Net change in the fair value of derivative liabilities	$ 0	$ 219,000	219,000	1,190,000
Fair value at end of year			$ 0	$ 163,000

Derivative Financial Instrume_5

Derivative Financial Instruments (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Debt Settlement Obligation (Details Narrative)
Net change in the fair value of derivative liabilities	$ 0	$ 219,000	$ 219,000	$ 1,190,000
Derivative liabilities			382,000	163,000
Extinguishment of derivative liabilities			$ 382,000	$ 3,460,000

Operating Lease (Details)

Operating Lease (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Lease Cost
Operating lease cost (included in general and administration in the Company's statement of operations)	$ 14,000	$ 14,000	$ 56,000	$ 56,000
Other Information
Cash paid for amounts included in the measurement of lease liabilities for the year ended December 31, 2021 and 2020	$ 14,000	$ 14,000	$ 55,000	$ 55,000
Weighted average remaining lease term - operating leases (in years)	1 year 9 months 18 days	2 years 9 months 18 days	3 years 1 month 6 days	3 years 1 month 6 days
Average discount rate - operating leases	10%	10%	10%	10%

Operating Lease (Details 1)

Operating Lease (Details 1) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating leases
Long-term right-of-use assets	$ 94,000	$ 107,000	$ 157,000
Short-term operating lease liabilities	55,000	39,000	38,000
Long-term operating lease liabilities	43,000	73,000	$ 125,000
Total operating lease liabilities	$ 98,000	$ 112,000

Operating Lease (Details 2)

Operating Lease (Details 2) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Operating Lease
2022	$ 43,000	$ 58,000
2023	59,000	59,000
2024	5,000	5,000
Total lease payment	107,000	122,000
Less: Imputed interest/present value discount	(9,000)	(10,000)
Present value of lease liabilities	$ 98,000	$ 112,000

Operating Lease (Details Narrat

Operating Lease (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Operating Lease
Operating lease payments, monthly	$ 4,000		$ 4,000
Lease expenses	$ 14,000	$ 14,000	$ 56,000	$ 56,000
Operating lease description	payments increasing 3% each year, and ending on January 31, 2024		payments increasing 3% each year, and ending on January 31, 2024

Stockholders Deficit (Details)

Stockholders Deficit (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Number of Warrant Shares
Number of warrants Beginning balance	68,981,234	27,405,475	100,574
Number of warrants Granted		55,000,000	27,304,901
Number of warrants Exercised		$ (13,424,241)	$ 0
Number of warrants Ending balance	68,981,234	68,981,234	27,405,475
Number of warrants exercisable Ending	68,981,234	68,981,234
Weighted Average Exercise Price, Granted		$ 0.05	$ 0.0045
Weighted Average Exercise Price
Weighted Average Exercise Price Beginning Balance	$ 0.042647
Weighted Average Exercise Price Outstanding Ending Balacce	0.042647
Weighted Average Exercise Price Exercisable Ending Balacce	0.042647
Exercise price range per share, Granted		0.05	0.0045
Weighted Average Exercise Price Beginning Balance	0.0274	0.011676	1.1185
Weighted Average Exercise Price Outstanding Ending Balacce	0.0274	0.042114	0.011676
Weighted Average Exercise Price Exercisable Ending Balacce		0.042114
Maximum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	0.1121	2.90	2.90
Exercise Price Range Per Share Outstanding Ending		2.90	2.90
Exercise Price Range Per Share Exercisable Ending balance	0.1121	2.90
Minimum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	0.005	0.0045	0.75
Exercise Price Range Per Share Outstanding Ending		0.0045	$ 0.0045
Exercise Price Range Per Share Exercisable Ending balance	0.005	$ 0.0045
Minimum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	0.0045
Exercise Price Range Per Share Outstanding Ending	0.0045
Exercise Price Range Per Share Exercisable Ending balance	0.0045
Maximum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	2.90
Exercise Price Range Per Share Outstanding Ending	2.90
Exercise Price Range Per Share Exercisable Ending balance	$ 2.90

Stockholders Deficit (Details 1

Stockholders Deficit (Details 1) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Warrant [Member]
Average Remaining Contractual Life (in years)		4 years
Weighted Average Exercise Price		$ 0.0045
Number Outstanding		13,349,242
Range of Exercise Prices		$ 0.0045
Warrant One [Member]
Average Remaining Contractual Life (in years)	4 years	4 years
Weighted Average Exercise Price	$ 0.0045	$ 0.085
Number Outstanding	13,349,242	588,235
Range of Exercise Prices	$ 0.0045	$ 0.085
Warrant Two [Member]
Average Remaining Contractual Life (in years)	4 years	5 years
Weighted Average Exercise Price	$ 0.085	$ 0.05
Number Outstanding	588,235	55,000,000
Range of Exercise Prices	$ 0.085	$ 0.05
Warrant Three [Member]
Average Remaining Contractual Life (in years)	5 years	3 years
Weighted Average Exercise Price	$ 0.05	$ 0.75
Number Outstanding	55,000,000	26,515
Range of Exercise Prices	$ 0.05	$ 0.75
Warrant Four [Member]
Average Remaining Contractual Life (in years)	3 years	3 years
Weighted Average Exercise Price	$ 0.75	$ 2.90
Number Outstanding	26,515	17,241
Range of Exercise Prices	$ 0.75	$ 2.90
Warrant Total [Member]
Average Remaining Contractual Life (in years)	4 years	4 years
Weighted Average Exercise Price	$ 0.042647	$ 0.042114
Number Outstanding	68,981,234	68,981,234
Warrant Total [Member] | Maximum [Member]
Range of Exercise Prices	$ 2.90	$ 2.90
Warrant Total [Member] | Minimum [Member]
Range of Exercise Prices	$ 0.0045	$ 0.0045
Warrant Five[Member]
Average Remaining Contractual Life (in years)	3 years
Weighted Average Exercise Price	$ 2.90
Number Outstanding	17,241
Range of Exercise Prices	$ 2.90

Stockholders Deficit (Details N

Stockholders Deficit (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Jan. 10, 2011	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Common stock consulting		134,853
Common stock issued		134,853
Common stock shares authorized		4,000,000,000		4,000,000,000	4,000,000,000
Common stock issued upon conversion of convertible notes payable and accrued interest, value		$ 6,000
Net proceeds from common stock				$ 1,525,000
Preferred stock, shares authorized		10,000,000		10,000,000	10,000,000
Preferred stock, per share		$ 0.01		$ 0.10	$ 0.10
Preferred stock, shares outstanding		0		0	0
Note issued					$ 316,000
Common stock issued		955,515,078		955,380,225	718,263,338
Intrinsic value of warrants		$ 717,000
Common stock issued for service, value		6,000	$ 16,000	$ 181,000	$ 39,000
Preferred stock value		0		0	0
Fair value of convertible note issued				$ 0	$ 803,000
Warrants issued to purchase common shares				638,000
October, 21 2010 [Member]
Preferred stock, shares authorized					10,000,000
Preferred stock, per share					$ 0.10
Additional shares of preferred stock					10,000,000
Warrant Total [Member]
Number of Warrants exercised					90,908	90,908
Warrant exercised, share				13,333,333
Common stock issued upon warrant exercised				12,349,726
Common stock issued				45,150,500
Fair value of common stock issued				$ 6,569,000
Intrinsic value of warrants		$ 464,000		473,000	$ 0
Warrant Total [Member] | January and July 2020 [Member] | Convertible Notes Payable One [Member]
Note issued				60,000
Fair value of convertible note issued				100,000
Conversion price					$ 0.0045
Exercise price					$ 0.75
Debt instrument, debt discount				$ 118,000
Maturity date				5 years
Warrants issued to purchase common shares				27,304,901
Series A Preferred Shares [Member]
Preferred stock, shares designated	100
Aggregate amount	$ 987,000
Preferred stock value	$ 329,000				$ 987,000
Series B Preferred Shares [Member]
Preferred stock, shares outstanding					36,667
Preferred stock, shares designated	100,000,000
Aggregate amount	$ 987,000
Preferred stock value	$ 329,000
Preferred stock, descriptions	such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share			such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share
Initial price of preferred stock	$ 2.50
Common Class Shares [Member] | November 2020 [Member]
Common stock shares authorized					4,000,000,000
Common stock issued upon conversion of convertible notes payable and accrued interest, value				$ 1,035,000
Net proceeds from common stock				$ 976,000
Common stock issued				139,661,006	712,431,992
Fair value of common stock issued for services, Value				$ 39,000
Shares issued for cash				119,666,450
Shares issued for cash value				$ 5,368,000
Warrants issued to purchase common stock				55
Warrants issued to purchase common stock exercisable price				$ 0.05
Warrants issued to purchase common stock expiration period				five years
Common stock issued for service, share				3,365,138
Common stock issued for service, value				$ 176,000
Stock issued for business purchase, shares				500,000
Stock issued for business purchase, value				$ 36,000
Common stock issued upon conversion of convertible notes payable and accrued interest, share				16,168,589
Common stock issued for debt settlement, share				460,829
Common stock issued for debt settlement, value				$ 88,000
Sale of common stock shares				436,337,203
Fair value of common stock issued for services, Shares				6,378,671
Common stock shares issued upon conversion of debt				233,748,884
Common stock shares issued upon debt settlement				35,967,234

Stock Options (Details)

Stock Options (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock options
Number of Options Shares, Beginning balance	83,133,001	58,133,001	633,001
Number of Options Shares, Granted		67,500,000	57,500,000
Number of Options Shares, Exercised		(42,500,000)	0
Number of Options Shares Outstanding Ending	83,133,001	83,133,001
Number of Options Shares exercisable Ending	53,433,547	20,236,826
Weighted Average Exercise Price, Granted		$ 0.0104	$ 0.0005
Number of warrants Ending balance		$ 83,133,001	$ 58,133,001
Weighted Average Exercise Price
Weighted Average Exercise Price Beginning Balance	$ 0.0274	$ 0.011676	$ 1.1185
Weighted Average Exercise Price Outstanding Ending Balacce	0.0274	0.042114	0.011676
Weighted Average Exercise Price Exercisable Ending Balacce	$ 0.0274	$ 0.0274	0.03704
Number of Options Shares exercisable Ending	53,433,547	20,236,826
Exercise price range per share, Granted		$ 0.05	0.0045
Maximum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	$ 0.1121	2.90	2.90
Exercise Price Range Per Share ,Granted		2.90	2.90
Exercise Price Range Per Share Exercisable Ending balance	0.1121	2.90
Exercise Price Range Per Share, Ending balance	0.1121
Minimum [Member]
Weighted Average Exercise Price
Exercise Price Range Per Share, Beginning balance	0.005	0.0045	0.75
Exercise Price Range Per Share ,Granted		0.0045	$ 0.0045
Exercise Price Range Per Share Exercisable Ending balance	0.005	$ 0.0045
Exercise Price Range Per Share, Ending balance	$ 0.005

Stock Options (Details 1)

Stock Options (Details 1) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Options Outstanding [Member]
Weighted average remaining contractual life (years)	6 years 9 months 18 days	6 years 9 months 18 days
Number of warrants outstanding	83,133,001	83,133,001
Weighted average exercise price	$ 0.03704	$ 0.03704
Option Exercisable [Member]
Weighted average exercise price	$ 0.0274	$ 0.0274
Weighted average remaining contractual life (years)	6 years 9 months 18 days	6 years 9 months 18 days
Number of warrants exercisable	53,433,547	20,236,826
Exercise Prices [Member] | Options Outstanding [Member]
Weighted average exercise price	$ 1,121,250,000	$ 1,121,250,000
Weighted average remaining contractual life (years)	2 years	2 years
Number of warrants outstanding	1	1
Exercise Prices [Member] | Option Exercisable [Member]
Weighted average exercise price	$ 1,121,250,000	$ 1,121,250,000
Weighted average remaining contractual life (years)	1 year	1 year
Number of warrants exercisable	1	1
Exercise Prices Two [Member] | Options Outstanding [Member]
Weighted average remaining contractual life (years)	6 years	6 years
Number of warrants outstanding	392,000	392,000
Weighted average exercise price	$ 3.125	$ 3.125
Exercise Prices Two [Member] | Option Exercisable [Member]
Weighted average exercise price	$ 3.125	$ 3.125
Weighted average remaining contractual life (years)	5 years	5 years
Number of warrants exercisable	392,000	392,000
Exercise Prices Three [Member] | Options Outstanding [Member]
Weighted average remaining contractual life (years)	9 years	9 years
Number of warrants outstanding	115,000	115,000
Weighted average exercise price	$ 2.05	$ 2.05
Exercise Prices Three [Member] | Option Exercisable [Member]
Weighted average exercise price	$ 2.05	$ 2.05
Weighted average remaining contractual life (years)	8 years	8 years
Number of warrants exercisable	115,000	115,000
Exercise Prices Four [Member] | Options Outstanding [Member]
Weighted average exercise price	$ 0.0375	$ 0.0375
Weighted average remaining contractual life (years)	10 years	10 years
Number of warrants outstanding	65,000,000	65,000,000
Exercise Prices Four [Member] | Option Exercisable [Member]
Weighted average exercise price	$ 0.0375	$ 0.0375
Weighted average remaining contractual life (years)	10 years	10 years
Number of warrants exercisable	36,748,634	3,551,913
Exercise Prices One [Member] | Options Outstanding [Member]
Weighted average remaining contractual life (years)	7 years	7 years
Number of warrants outstanding	126,000	126,000
Weighted average exercise price	$ 2.85	$ 2.85
Exercise Prices One [Member] | Option Exercisable [Member]
Weighted average remaining contractual life (years)	6 years	6 years
Number of warrants exercisable	126,000	126,000
Weighted average exercise price	$ 2.85	$ 2.85
Exercise Prices Five [Member] | Options Outstanding [Member]
Weighted average exercise price	$ 0.005	$ 0.005
Weighted average remaining contractual life (years)	10 years	10 years
Number of warrants exercisable	17,500,000	17,500,000
Exercise Prices Five [Member] | Option Exercisable [Member]
Weighted average remaining contractual life (years)	10 years	10 years
Number of warrants outstanding	16,051,912	16,051,912
Weighted average exercise price	$ 0.005	$ 0.005

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Nov. 30, 2017
Option shares		65,000,000
Exercise price		$ 0.0375
Share based compensation	$ 1,636,000	$ 368,000	$ 506,000
Unamortized stock compensation	1,300,000	$ 5,032,000	$ 3,600,000
Intrinsic value of warrants	$ 717,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		400,000,000		100,000,000
Total fair value		$ 2,657,000
Options, Grants in Period		67,500,000	57,500,000
Options, exercised during period		42,500,000	0
Stock Option [Member]
Option shares		2,500,000
Exercise price		$ 0.005	$ 0.005
Total fair value		$ 5,400,000	$ 3,853,000
Stock compensation expense, Additional		$ 2,712,000
Common stock, shares issued upon cashless exercise of options		39,955,655
Options, Grants in Period		67,500,000	57,500,000
Discount rate		1.46%	0.95%
Volatility rate		137%	604%
Options, exercised during period		42,500,000
Options outstanding, estimated life		10 years	10 years
Stock Option [Member] | February 2021 [Member]
Share based compensation		$ 3,675,000
Intrinsic value of warrants		$ 3,225,000	$ 0
Options outstanding, estimated life		10 years
Stock option granted		12,250,000

Income Tax Provision (Details)

Income Tax Provision (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Provision
Federal statutory income tax rate	21%	21%
State tax, net of federal benefit	7%	5%
Change in valuation allowance on net operating loss carry-forwards	(28.00%)	(26.00%)
Effective income tax rate	0%	0%

Income Tax Provision (Details 1

Income Tax Provision (Details 1) - Income Tax Provision [Member] - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Stock-based compensation	$ 2,698,000	$ 702,000
Private placement costs	394,000	366,000
Operating lease liability	31,000	42,000
Loss on extinguishment of debt	1,858,000	1,697,000
Net operating loss carryforwards	6,494,000	5,946,000
Gross deferred tax assets	11,475,000	8,753,000
Less valuation allowance	$ (11,475,000)	$ (8,753,000)

Income Tax Provision (Details N

Income Tax Provision (Details Narrative) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Federal [Member]
Net operating loss carry-forwards	$ 23	$ 21.4
Carryforwards expiry year	2040
State [Member]
Net operating loss carry-forwards	$ 9.8	$ 12.5
Carryforwards expiry year	2040

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022	Dec. 31, 2021
Common stock shares issued for services, shares				134,853
Common stock shares issued for services, amount				$ 6,000
Subsequent Event [Member]
Common stock shares issued for services, shares	2,500,000	5,000,000	96,083
Common stock shares issued for services, amount	$ 56,000	$ 104,000	$ 4,000
Proceed from stock options warrants		$ 1,000,000
Warrant excercisable per share		$ 0.05
Warrant excercisable period		5 years
Number of warrant extinguish		605,476
Proceeds from warrant extinguish		$ 165,000
Subsequent Event [Member] | Minimum [Member]
Excercise price of stock warrant		$ 0.02
Subsequent Event [Member] | Maximum [Member]
Excercise price of stock warrant		$ 0.05